Montelukast induced acute hepatocellular liver injury

Journal of Postgraduate Medicine

Volumn 55, Issue 2, 2009, Pages 141-142

  Harugeri, A ^a   Parthasarathi, G ^a   Sharma, J ^b   D'souza, G A ^b   Ramesh, M ^a  

^a JSS COLLEGE OF PHARMACY   (India)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Adverse drug reaction; Hepatitis; Leukotriene antagonist; Liver injury; Montelukast

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; BUDESONIDE PLUS FORMOTEROL; DEXAMETHASONE; FLUTICASONE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; MONTELUKAST; OMEPRAZOLE; PREDNISOLONE; SALBUTAMOL;

ACUTE DISEASE; ADULT; ANAMNESIS; ARTICLE; ASTHMA; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE DURATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; HUMAN; LIVER CELL DAMAGE; LIVER EXAMINATION; MALE; METERED DOSE INHALER; PATIENT MONITORING; PRESCRIPTION; TREATMENT OUTCOME;

ACETATES; ANTI-ASTHMATIC AGENTS; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; QUINOLINES;

EID: 67651152653     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.52850     Document Type: Article

References (12)

1. th ed. Philadelphia: Saunders; 2003. p. 755-832.
2. th ed. Vol. 2. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 923-1004.
3. Lucena MI, García-Cortés M, Cueto R, Lopez-Duran J, Andrade RJ. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol 2008;22:141-58.
4. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I: A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30.
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
6. Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008;66:758-66.
7. Cuchacovich R, Justiniano M, Espinoza LR. Churg-Strauss syndrome associated with leukotriene receptor antagonists (LTRA). Clin Rheumatol 2007;26:1769-71.
8. Actis GC, Bugianesi E, Ottobrelli A, Rizzetto M. Fatal liver failure following food supplements during chronic treatment with montelukast. Dig Liver Dis 2007;39:953-5.
9. WHO ADR database search interface [homepage on the internet]. No date [updated 2008 Jun 26; cited 2008 Jun 26]. Available from: https://vigisearch. who-umc.org/.
10. Sass DA, Chopra KB, Wu T. A case of montelukast induced hepatotoxicity. Am J Gastroenterol 2003;98:704-5.
11. Goldstein M F, Anoia J, Black M. Montelukast induced hepatitis. Ann Intern Med 2004;140:586-7.
12. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology 2008;47: 1401-15.